You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Lung Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 2 | Results 1 - 10 of 13

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

John McCann, MD
Cancer - Lung

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Recruiting

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

John McCann, MD
Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer

Victor Pinto-Plata, MD
Cancer - Lung, Pulmonary/ Critical Care

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

John McCann, MD
Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

John McCann, MD
Cancer, Cancer - Lung

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting
Page 1 of 2 | Results 1 - 10 of 13